Fluid Management in Patients Undergoing Cardiac Surgery

Study Overview
=================
Brief Summary
-----------------
Background: Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intra- and extracellular water content and plasma electrolyte compositions and have a major impact on organ function and outcome. Despite continuing evaluation no superiority of one particular type of fluid has been reached so far. To the best of the investigators' knowledge no study in humans has ever assessed whether the type of crystalloid fluid given for fluid resuscitation in patients undergoing cardiac surgery has an impact on hemodynamic stability and cardiac function so far. Nonetheless in the animal model it was shown that the choice of crystalloid fluid may greatly influence cardiac performance Primary Aim: In this study the investigators want to clarify whether a balanced type acetate-buffered fluid solution in patients undergoing cardiac surgery is associated with better hemodynamic stability and cardiac function than a lactate-buffered crystalloid solute.

Official Title
-----------------
Fluid Management in Patients Undergoing Cardiac Surgery - Effects of an Acetate Versus Lactate Buffered Balanced Infusion Solution on Hemodynamic Stability, a Randomized Controlled Double-blind Trial

Conditions
-----------------
Critical Illness

Intervention / Treatment
-----------------
* Procedure: perioperative hemodynamic management with vasoactive medications (norepinephrine, adrenaline ect)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Elective single heart valve replacement Elective double valve replacement Elective single or double valve replacement and coronary artery bypass grafting Exclusion Criteria: Patients unable to give informed consent Patients younger than 18 years of age or older than 80 years Pregnancy or breastfeeding Ejection fraction (EF) of less than 30% preoperatively Preexisting renal insufficiency with a glomerular filtration rate below 30ml/min Patients transferred form the intensive care unit to the operating theater Emergency operation Reoperation Patients planned for fast-track surgery Patients planned for minimal extracorporal circuits Preexisting anemia requiring immediate perioperative blood transfusion Chronic inflammatory diseases Any signs of infection or sepsis Limitation of full therapy (e.g. Jehowa's witnesses)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Ringer lactate<br>Fluid resuscitation will be performed with lactated Ringers during the perioperative period. Perioperative hemodynamic management will be performed according to a specified treatment protocol. | Procedure: perioperative hemodynamic management with vasoactive medications (norepinephrine, adrenaline ect)<br>* Perioperative hemodynamic management will be performed according to a specified treatment protocol.<br>|
| Active Comparator: Ringer acetate<br>Fluid resuscitation will be performed with acetated Ringers during the perioperative period. Perioperative hemodynamic management will be performed according to a specified treatment protocol. | Procedure: perioperative hemodynamic management with vasoactive medications (norepinephrine, adrenaline ect)<br>* Perioperative hemodynamic management will be performed according to a specified treatment protocol.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Cumulative dose of inopressors (norepinephrine and epinephrine) per kg bodyweight/hour during the perioperative period |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time on inopressors |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 
| Cumulative dose of inodilators |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 
| Time on inodilators |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 
| Cumulative dose of vasodilatators |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 
| Time on vasodilatators |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 
| Total amount of fluid |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 
| Changes in acid-base status |  | Perioperative period (induction of anesthesia until extubation in the intensive care unit, usually less than 24 hours)) | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
fluid management, critical illness, hemodynamics, buffered infusates